ETF constituents for IDNA

Below, a list of constituents for IDNA (iShares Genomics Immunology and Healthcare ETF) is shown. In total, IDNA consists of 57 securities.

Note: The data shown here is as of date Sep 30, 2025 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
RVMD REVOLUTION MEDICINES INC Health Care Equity 6284898.21 4.89
INCY INCYTE CORP Health Care Equity 6027581.56 4.69
CELC CELCUITY INC Health Care Equity 6014776.0 4.68
GMAB GENMAB Health Care Equity 5878141.6 4.57
ACLX ARCELLX INC Health Care Equity 5669659.8 4.41
6160 BEONE MEDICINES AG Health Care Equity 5425258.14 4.22
REGN REGENERON PHARMACEUTICALS INC Health Care Equity 5285349.3 4.11
AZN ASTRAZENECA PLC Health Care Equity 5106018.86 3.97
MRK MERCK & CO INC Health Care Equity 4962584.0 3.86
TWST TWIST BIOSCIENCE CORP Health Care Equity 4821499.16 3.75
GSK GLAXOSMITHKLINE Health Care Equity 4756283.39 3.7
ROG ROCHE HOLDING PAR AG Health Care Equity 4589947.02 3.57
SAN SANOFI SA Health Care Equity 4535506.15 3.53
BNTX BIONTECH SE ADR Health Care Equity 4353246.45 3.39
MRNA MODERNA INC Health Care Equity 4323585.5 3.37
4502 TAKEDA PHARMACEUTICAL LTD Health Care Equity 4277821.61 3.33
EXEL EXELIXIS INC Health Care Equity 4138725.06 3.22
JANX JANUX THERAPEUTICS INC Health Care Equity 3411228.75 2.65
ABCL ABCELLERA BIOLOGICS INC Health Care Equity 3250696.83 2.53
NVAX NOVAVAX INC Health Care Equity 3230370.9 2.51
IMNM IMMUNOME INC Health Care Equity 3207252.8 2.5
RCUS ARCUS BIOSCIENCES INC Health Care Equity 2989261.8 2.33
BCRX BIOCRYST PHARMACEUTICALS INC Health Care Equity 2948707.8 2.29
XNCR XENCOR INC Health Care Equity 2398273.28 1.87
302440 SK BIOSCIENCE LTD Health Care Equity 2388426.43 1.86
KURA KURA ONCOLOGY INC Health Care Equity 2285147.52 1.78
GERN GERON CORP Health Care Equity 1942928.64 1.51
VLA VALNEVA Health Care Equity 1651845.25 1.29
IOVA IOVANCE BIOTHERAPEUTICS INC Health Care Equity 1578150.42 1.23
PACB PACIFIC BIOSCIENCES OF CALIFORNIA Health Care Equity 1388823.81 1.08
VIR VIR BIOTECHNOLOGY INC Health Care Equity 1387265.66 1.08
ORIC ORIC PHARMACEUTICALS INC Health Care Equity 1345440.4 1.05
RIGL RIGEL PHARMACEUTICALS INC Health Care Equity 1292912.22 1.01
DNA GINKGO BIOWORKS HOLDINGS INC CLASS Health Care Equity 1260146.29 0.98
MREO MEREO BIOPHARMA GROUP ADR REPRESEN Health Care Equity 723756.0 0.56
ARCT ARCTURUS THERAPEUTICS HOLDINGS INC Health Care Equity 661525.53 0.51
IBRX IMMUNITYBIO INC Health Care Equity 614398.82 0.48
CRSP CRISPR THERAPEUTICS AG Health Care Equity 532529.16 0.41
4528 ONO PHARMACEUTICAL LTD Health Care Equity 417505.8 0.32
LGND LIGAND PHARMACEUTICALS INC Health Care Equity 349734.77 0.27
BEAM BEAM THERAPEUTICS INC Health Care Equity 235571.49 0.18
XTSLA BLK CSH FND TREASURY SL AGENCY Cash and/or Derivatives Money Market 160000.0 0.12
NTLA INTELLIA THERAPEUTICS INC Health Care Equity 139573.23 0.11
JPY JPY CASH Cash and/or Derivatives Cash 98465.74 0.08
USD USD CASH Cash and/or Derivatives Cash 56045.61 0.04
GBP GBP CASH Cash and/or Derivatives Cash 46112.33 0.04
HBCFT CASH COLLATERAL USD HBCFT Cash and/or Derivatives Cash Collateral and Margins 17000.0 0.01
DKK DKK CASH Cash and/or Derivatives Cash 10803.67 0.01
HKD HKD CASH Cash and/or Derivatives Cash 10227.51 0.01
EUR EUR CASH Cash and/or Derivatives Cash 4892.16 0.0
KRW KRW CASH Cash and/or Derivatives Cash 167.99 0.0
TWD TWD CASH Cash and/or Derivatives Cash 171.36 0.0
CHF CHF CASH Cash and/or Derivatives Cash 172.34 0.0
nan OMNIAB INC $15.00 VESTING Prvt Health Care Equity 0.19 0.0
nan OMNIAB INC $12.50 VESTING Prvt Health Care Equity 0.19 0.0
IXCZ5 E-MINI HEALTH CARE SECTOR DEC 25 Cash and/or Derivatives Futures 0.0 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. nan nan nan nan nan